Biosign is a medical device company. Their products include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The company is publicly listed on the TSX - Venture Exchange. They have been a listed company since July 14, 2006. Their auditors are Collins Barrow LLP and our corporate filings are available on SEDAR.